These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Effect of ethamsylate and aminocaproic acid on menstrual blood loss in women using intrauterine devices. Kasonde JM; Bonnar J Br Med J; 1975 Oct; 4(5987):21-2. PubMed ID: 1174906 [No Abstract] [Full Text] [Related]
6. Aminocaproic acid and menstrual loss in women using intrauterine devices. Kasonde JM; Bonnar J Br Med J; 1975 Oct; 4(5987):17-9. PubMed ID: 1174902 [TBL] [Abstract][Full Text] [Related]
7. Cerebral sinus thrombosis as a potential hazard of antifibrinolytic treatment in menorrhagia. Achiron A; Gornish M; Melamed E Stroke; 1990 May; 21(5):817-9. PubMed ID: 2339463 [TBL] [Abstract][Full Text] [Related]
8. EXPERIENCES WITH EPSILON-AMINOCAPROIC ACID (EPSILON-ACA) IN THE TREATMENT OF PROFUSE MENSTRUATION. NILSSON IM; BJOERKMAN SE Acta Med Scand; 1965 Apr; 177():445-57. PubMed ID: 14296605 [No Abstract] [Full Text] [Related]
9. Epsilon-aminocaproic acid for treatment of fibrinolysis during liver transplantation. Kang Y; Lewis JH; Navalgund A; Russell MW; Bontempo FA; Niren LS; Starzl TE Anesthesiology; 1987 Jun; 66(6):766-73. PubMed ID: 3296855 [TBL] [Abstract][Full Text] [Related]
10. Treatment of menorrhagia. Nilsson L; Rybo G Am J Obstet Gynecol; 1971 Jul; 110(5):713-20. PubMed ID: 5563236 [No Abstract] [Full Text] [Related]
11. Histochemical study of the changes in endometrial fibrinolytic activity during treatment of menometrorrhagia with anitfbrinolytics. Koutský J; Jirásek JE Gynaecologia; 1969; 168(4):241-7. PubMed ID: 5310095 [No Abstract] [Full Text] [Related]
12. [Hemostasis system in patients with Quincke's edema before and after treatment with epsilon-aminocaproic acid]. Sawicka B; Zawisza E; Pezko H Otolaryngol Pol; 1984; 38(6):511-5. PubMed ID: 6533528 [No Abstract] [Full Text] [Related]
13. [Experience in the treatment of dysmenorrhea and the premenstrual syndrome with epsilon-aminocaproic acid]. Pliaĭsner K Akush Ginekol (Mosk); 1971 Aug; 47(8):75. PubMed ID: 5170539 [No Abstract] [Full Text] [Related]
14. Successful epsilon-aminocaproic acid therapy in a patient with unexplained hematuria. MacGregor D; Saunders EF; Barkin M; Balfe JW Clin Pediatr (Phila); 1977 Feb; 16(2):167-8. PubMed ID: 832441 [No Abstract] [Full Text] [Related]
16. [On the use of epsilon-aminocaproic acid for prevention of complications caused by iodized contrast media]. Patriarca G; Fais G Folia Allergol (Roma); 1970; 17(2):208-13. PubMed ID: 4316332 [No Abstract] [Full Text] [Related]
17. [Epsilon-aminocaproic acid for reactive leprous conditions: preliminary note]. Mafart Y; Ducloux M Bull Soc Med Afr Noire Lang Fr; 1970; 15(2):300-4. PubMed ID: 5526014 [No Abstract] [Full Text] [Related]
18. Pubertal hemorrhages in girls with a hemorrhagic disorder. Comments on management. Van Creveld S; Schellekens LA Clin Pediatr (Phila); 1969 Jul; 8(7):398-9. PubMed ID: 5305932 [No Abstract] [Full Text] [Related]
19. [Experience in the preventive use of epsilon-aminocaproic acid in women with arterial hypotension]. Susloparov LA Akush Ginekol (Mosk); 1970 Nov; 46(11):45-8. PubMed ID: 5519533 [No Abstract] [Full Text] [Related]
20. [A manageable and effective treatment of functional uterine hemorrhage: epsilon-aminocaproic acid]. Bostard P Therapeutique; 1969 May; 45(5):546-7. PubMed ID: 5791839 [No Abstract] [Full Text] [Related] [Next] [New Search]